Ingalls & Snyder LLC’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $233K | Sell |
435
-100
| -19% | -$53.6K | 0.01% | 393 |
|
|
2025
Q1 | $225K | Buy |
535
+5
| +0.9% | +$2.1K | 0.01% | 382 |
|
|
2024
Q4 | $219K | Hold |
530
| – | – | 0.01% | 381 |
|
|
2024
Q3 | $268K | Hold |
530
| – | – | 0.01% | 367 |
|
|
2024
Q2 | $258K | Hold |
530
| – | – | 0.01% | 348 |
|
|
2024
Q1 | $286K | Hold |
530
| – | – | 0.01% | 341 |
|
|
2023
Q4 | $294K | Hold |
530
| – | – | 0.01% | 341 |
|
|
2023
Q3 | $232K | Hold |
530
| – | – | 0.01% | 367 |
|
|
2023
Q2 | $266K | Buy |
530
+50
| +10% | +$25.1K | 0.01% | 355 |
|
|
2023
Q1 | $240K | Buy |
+480
| New | +$240K | 0.01% | 362 |
|
|
2022
Q2 | – | Sell |
-508
| Closed | -$278K | – | 430 |
|
|
2022
Q1 | $278K | Hold |
508
| – | – | 0.01% | 364 |
|
|
2021
Q4 | $334K | Hold |
508
| – | – | 0.02% | 341 |
|
|
2021
Q3 | $316K | Hold |
508
| – | – | 0.01% | 354 |
|
|
2021
Q2 | $321K | Hold |
508
| – | – | 0.01% | 358 |
|
|
2021
Q1 | $249K | Buy |
508
+2
| +0.4% | +$980 | 0.01% | 375 |
|
|
2020
Q4 | $253K | Buy |
+506
| New | +$253K | 0.01% | 362 |
|
|
2020
Q3 | – | Sell |
-806
| Closed | -$266K | – | 391 |
|
|
2020
Q2 | $266K | Buy |
+806
| New | +$266K | 0.02% | 323 |
|
|
2020
Q1 | – | Sell |
-841
| Closed | -$220K | – | 405 |
|
|
2019
Q4 | $220K | Sell |
841
-2
| -0.2% | -$523 | 0.01% | 350 |
|
|
2019
Q3 | $229K | Buy |
+843
| New | +$229K | 0.01% | 372 |
|